Muscarinic acetylcholine receptors (mAChRs) are present in high concentrations in the CNS and are known to couple to a number of biochemical effector systems, such as stimulated phosphoinositide (PPI) turnover, inhibition of adenylate cyclase, and activation of guanylate cyclase (for review, see Nathanson, 1987). Subtypes of the mAChR have also been proposed on the basis of the differential ability with which pirenzepine binds to the receptor and inhibits the functional responses. Pirenzepine has a high affinity for the MI subtype, whereas it has a low affinity for both the M2 and M3 subtypes. The latter can be differentiated on the basis of the relative selectivity of AF-DX 1 16
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-[(diethylamino)methyl]-l-piperidinyl]acetyl]-5,11
-dihydro-6H-pyrido[ 2,341 [ 1,4]benzodiazepin-6-0ne} for Mz and 4-DAMP (4-diphenylacetoxy-N-methylpiperidine methiodide) for M3 (Doods et al., 1987) . The M2 and M3 receptors are principally found in heart and exocrine glands, respectively. In neural tissues, the MI subtype predominates and couples to PPI turnover. In the present study, we demonstrate the presence of a high density of high-molecular-weight (M, > 80,000) mAChRs of the M3 subtype in a neural cell line, human SK-N-SH neuroblastoma. Furthermore, these receptors are shown to couple functionally to inositol lipid hydrolysis. 
MATERIALS AND METHODS

Cell culture and biochemical determinations
Human SK-N-SH neuroblastoma cells were cultured under conditions similar to those previously described (Fisher and Snider, 1987) . In the experiments reported, 14-22-day-old cells were used. Measurement of the binding of radioligands to intact cells and monitoring of PPI hydrolysis were as previously described (Fisher and Snider, 1987) . Protein content was determined by the method of Geiger and Bessman (1972) .
Covalent labeling of muscarinic receptors
Slices of adult rat cerebral cortex (Heacock et al., 1987) or intact SK-N-SH cells were preincubated [in buffer A, minus Ca2+ (Fisher and Snider, 1987) ] in the presence or absence of 10 pM atropine for 15 min at 37"C, followed by addition of 5-10 nM cyclized [3H]PrBCM (Hunter and Nathanson, 1986) . After 30 min at 37"C, tissues were pelleted by centrifugation at low speed, washed twice with cold buffer A (minus Ca"), and then homogenized at 4°C in 62.5 mMTris-HC1 (pH 6.8) containing the protease inhibitors phenylmethylsulfonyl fluoride (1 mM), phenanthroline (0.5 mM), pepstatin A (0.1 p M ) , soybean trypsin inhibitor (1 0 pg/ml), and EGTA (2 mM). Proteins were solubilized in 2% (wt/vol) sodium dodecyl sulfate (SDS), 1% 6-mercaptoethanol, and 8 M urea. In some experiments, disulfide bond formation was blocked by alkylation with 0.2 A 4 iodoacetamide (Dadi and Morris, 1984) . Samples were electrophoresed on 10% polyacrylamide gels (Laemmli, 1970) , which contained 4 M urea. Coomassie Blue-stained gels were dried and then cut into 2-mm slices for determination of radioactivity (Hunter and Nathanson, 1986) . Alternatively, labeled proteins were visualized by fluorography .
Data analysis
Results are expressed as mean f SEM values. Evidence that the M3 rather than the M2 receptor is present was obtained from studies with AF-DX 116 (M2 selective) and 4-DAMP (M3 selective). Both antagonists completely displaced [3H]NMS binding, but 4-DAMP was I ,000-fold more potent (Fig. 1 ). All three antagonists, i.e., pirenzepine, AF-DX 1 16, and 4-DAMP, blocked stimulated PPI hydrolysis with potencies that reflected the abilities of these agents to bind to the mAChR. Previously, we have shown that pirenzepine is a weak competitive inhibitor of stimulated PPI hydrolysis in SK-N-SH cells (Ki = 250 nA4) (Fisher and Snider, 1987) . However, 4-DAMP is -100-fold more potent than pirenzepine in the inhibition of stimulated PPI turnover, whereas AF-DX 1 16 is 10-fold less potent (Fig.  2) . Inclusion of increasing concentrations of both 4-DAMP and AF-DX 116 resulted in a parallel shift in the dose-response curves to carbamoylcholine, which is a characteristic of a competitive antagonist. Schild regression analysis of the data yielded K, values of 1-3 nM for 4-DAMP and 1.5-2 pM for AF-DX 1 16. These values are in good agreement with the affinity constants obtained from the radioligand binding data shown in Fig. 1 . The differential abilities of pirenzepine, AF-DX 116, and 4-DAMP to bind mAChRs in SK-N-SH cells are very similar to that observed for the submandibular gland (an M3-containing tissue) but differs markedly from that observed in either the atrium (M2 containing) or hippocampus (MI containing) (Doods et al., 1987) . That these three antagonists also exhibit the same relative affinities for inhibition of stimulated PPI turnover indicates that activation of M3 receptors can lead to the hydrolysis of inositol lipids. The possibility that the pharmacological characteristics of the mAChRs in SIC-N-SH cells might reflect the presence of different molecular species compared with that in an M,-containing tissue, such as the rat cerebral cortex, was explored. Intact SK-N-SH cells or rat cerebral cortex slices were labeled with [3H]PrBCM, and the labeled peptides were analyzed by SDS-urea gel electrophoresis (Fig. 3) . Rat cortex contained a single species of M, 66,000 f 1,000 (n = 6), whereas SK-N-SH cells exhibited [3H]PrBCM-labeled peptides of considerably larger size with the major species of MI 98,000 f 2,000 (n = 6). The labeling of the less abundant M, 81,000 f 1,300 (n = 6) species varied but on the average accounted for approximately one-third of the total. In an experiment in which SK-N-SH cells were directly homogenized in SDS-containing buffer, both species were present; however, the portion of radioactivity in the MI 81,000 species was reduced to 20% of the total. Thus, the possibility that the lower-M, species is, at least in part, derived from proteolysis of the MI 98,000 species cannot be ruled out. Rapid proteolysis of the mAChR in heart cells has been described (Hunter and Nathanson, 1986) . Alternatively, because mAChRs are glycoproteins (Rauh et al., 1986) , the MI 8 1,000 species may represent a reduced glycosylation state of the receptor. Alkylation of sulfhydryl groups by iodoacetamide treatment had no effect on migration of [3H]PrBCM-labeled peptides (Fig. 3, inset) ; thus, the higher molecular weight of the SK-N-SH mAChRs does not appear to result from intermolecular disulfide bond formation. Differences in proteolytic activity between rat cortex and SK-N-SH cells do not appear to be involved, because mixing of unlabeled rat cortex with labeled SK-N-SH cells before sample preparation had no effect on electrophoretic migration of the mAChRs. It may be that the SK-N-SH mAChR is more heavily glycosylated than that in the cortex, a possibility that can be addressed by endoglycosidase treatment (Rauh et al., 1986; Liang et al., 1987) . Alternatively, the molecular and pharmacological characteristics of the mAChR expressed by SK-N-SH cells may reflect the presence of a receptor protein distinct from the species that predominates in the cerebral cortex.
RESULTS AND DISCUSSION
Specific binding of [3H]NMS and [3H]QNB to mAChRs
Muscarinic receptors thus far identified by [3H]PrBCMlabeling appear to fall into two groups: (a) those of M, 65,000-80,000, found in brain (Venter, 1983; Dadi and Morris, 1984; Large et al., 1986 ), heart (Venter, 1983 Hunter and Nathanson, 1986) , and NG108-15 cells (Hootman et al., 1985; Liang et al., 1987) > 80,000, found in SK-N-SH cells, exocrine glands (Hootman et al., 1985) , and 1321N1 astrocytoma cells (Liang et al., 1987) . Data presently available are suggestive of but insufficient to conclude whether or not the pharmacologically defined mAChR subtypes can be definitively assigned to either of these groups. Of the mAChRs thus far sequenced (Bonner et al., 1987) , three are of similar size, whereas one (termed m3) is considerably larger. Screening of SK-N-SH cell mRNAs with the appropriate molecular probes will be necessary for determining whether its mAChR belongs to the latter category.
The present results implicating the M3 subtype in PPI hydrolysis, together with previous reports implicating both MI and M2 subtypes , indicate that multiple mAChR subtypes with distinct pharmacological and molecular characteristics are able to couple to the same functional response.
